- Home
- RGF vs NURO Comparison
RGF vs NURO Comparison
Compare RGF & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGF
- NURO
- Stock Information
- Founded
- RGF 2016
- NURO 1996
- Country
- RGF United States
- NURO United States
- Employees
- RGF N/A
- NURO N/A
- Industry
- RGF Packaged Foods
- NURO Medical/Dental Instruments
- Sector
- RGF Consumer Staples
- NURO Health Care
- Exchange
- RGF Nasdaq
- NURO Nasdaq
- Market Cap
- RGF 6.4M
- NURO 7.6M
- IPO Year
- RGF 2021
- NURO N/A
- Fundamental
- Price
- RGF $0.24
- NURO $4.15
- Analyst Decision
- RGF Hold
- NURO
- Analyst Count
- RGF 1
- NURO 0
- Target Price
- RGF $0.50
- NURO N/A
- AVG Volume (30 Days)
- RGF 132.4K
- NURO 20.0K
- Earning Date
- RGF 12-03-2024
- NURO 11-05-2024
- Dividend Yield
- RGF N/A
- NURO N/A
- EPS Growth
- RGF N/A
- NURO N/A
- EPS
- RGF N/A
- NURO N/A
- Revenue
- RGF $156,379,000.00
- NURO $3,767,764.00
- Revenue This Year
- RGF $23.67
- NURO N/A
- Revenue Next Year
- RGF N/A
- NURO N/A
- P/E Ratio
- RGF N/A
- NURO N/A
- Revenue Growth
- RGF 18.88
- NURO N/A
- 52 Week Low
- RGF $0.21
- NURO $2.66
- 52 Week High
- RGF $2.10
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- RGF 27.82
- NURO 55.34
- Support Level
- RGF $0.24
- NURO $3.59
- Resistance Level
- RGF $0.27
- NURO $4.56
- Average True Range (ATR)
- RGF 0.02
- NURO 0.33
- MACD
- RGF -0.00
- NURO 0.05
- Stochastic Oscillator
- RGF 8.16
- NURO 69.40
About RGF The Real Good Food Company Inc.
The Real Good Food Co Inc is a frozen food company that develops, markets, and manufactures foods high in protein, low in sugar, and gluten- and grain-free. The company produces breakfast sandwiches, entrees, and other products, primarily sold in the U.S. frozen food category. All of its revenue is derived from the United States.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.